newsfilter
← Latest News
Business Wire·

Pan-Cancer Analysis Suggests Fibroblast Activation Protein (FAP) is an Attractive Target for Peptide-Targeted Radionuclide Therapy with FAP-2286

High expression of FAP, the target of radionuclide therapeutic development candidate FAP-2286, was observed across multiple tumor types and correlated with FAP-2286 binding Clovis Oncology's clinical development of FAP-2286 is underway with the Ph